RxDoctor Payments Data

Patricia Woeltz, APRN

Acute Care · Decatur, GANPI 1336679729

Payments from drug & device makers

$476in general payments, 2019–2025

Across 28 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$128
  • Pfizer$99
  • Edwards Lifesciences$37
  • Philips North America LLC$36
  • AbbVie$31
  • Exact Sciences$29
  • plus $116 from 7 others

What the payments were for

  • Food & beverage$476100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$476 in reported general payments places this provider in the 60th percentile of 679 acute care providers in Georgia.

See all acute care providers in Georgia

Medicare billing

Part B allowed, 2024
$39,024
Medicare patients
164
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$35,979
OzempicSemaglutide26$26,440
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog32$21,402
JardianceEmpagliflozin15$16,833
TrulicityDulaglutide14$13,455
RybelsusSemaglutide14$13,323
FarxigaDapagliflozin Propanediol11$6,243
TrintellixVortioxetine Hydrobromide13$6,197
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,482
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$1,951
Atorvastatin Calcium142$1,281
Pantoprazole Sodium103$1,196
Buspirone Hcl50$1,083
SynthroidLevothyroxine Sodium11$1,065
Bupropion XlBupropion Hcl22$1,016

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$128$39,76440 claims
PfizerEliquis$99$35,97922 claims
AstraZenecaFarxiga$13$6,24311 claims
AbbVieSynthroid$31$1,06511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 679 acute care providers in Georgia.

Other acute care in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →